Secondary metabolites of Cynodon dactylon as an antagonist to angiotensin II type1 receptor: Novel in silico drug targeting approach for diabetic retinopathy

Journal of Pharmacology and Pharmacotherapeutics

Volumn 3, Issue 1, 2012, Pages 20-25

  Jananie, R ^a   Priya, V ^a   Vijayalakshmi, K ^a  

^a BHARATHI WOMEN S COLLEGE   (India)

Author keywords

Angiotensin II type 1 receptor; Cynodon dactylon; diabetic retinopathy; in silico analysis

Indexed keywords

9,12 OCTADECADIENOYL CHLORIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIAZOPROGESTERONE; DIDODECYL PHTHALATE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPUTER MODEL; CYNODON DACTYLON; DIABETIC RETINOPATHY; DRUG TARGETING; HYDROGEN BOND; LIGAND BINDING; MOLECULAR DOCKING; PROTEIN DOMAIN; STRUCTURE ANALYSIS;

EID: 84878707293     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.92497     Document Type: Article

References (16)

1. Moss SE, Klein R, Klein BE. The 14- year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105: 998-1003.
2. Chu KY, Leung PS. Angiotensin II in type 2 diabetes mellitus. Curr Protein Pept Sci 2009; 10: 75-84.
3. Wilkinson-Berka JL. Angiotensin and Diabetic Retinopathy. Inter J Biochem Cell Biol 2006; 38: 752-65.
4. Wilkinson-Berka JL, Duncan J, Campbell. (Pro) renin receptor: A treatment target for Diabetic Retinopathy? Diabetes 2009; 58: 1485-87.
5. Clermont A, Bursell SE, Feener EP. Role of the Angiotensin II Type 1 receptor in the pathogenesis of Diabetic Retinopathy effect of blood pressure control and beyond. J Hypertens Suppl 2006; 24: 573-80.
6. Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, et al. Suppression of diabetes -induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor- kappa B pathway. Invest Ophthalmol Vis Sci 2007; 48: 4342-50.
7. Kirtikar KK, Basu BD. Indian Medicinal Plants. India: Lalit Mohan Publication; 1980. p. 2650.
8. Chopra RN, Nayer SL, Chopra IC. Glossary of Indian Medicinal Plants. CSIR, New Delhi: Publication and Information Directorate; 1999. p. 88.
9. Jananie RK, Priya V, Vijayalakshmi K. Determination of bioactive components of Cynodon dactylon by GCMS analysis. NY Sci J 2011; 4: 16-20.
10. Townsend RR, Di Pette DJ. Pressor doses of Angiotensin II increases insulin -mediated glucose uptake in normotensive men. Am J Physiol 1993; 265: E362-66.
11. Lupi R, Del GS, Bugliani M, Boggi U, Mosca F, Torri S, et al. The direct effect of Angiotensin -converting enzyme inhibitors zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 2006; 154: 355-61.
12. Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006; 55: 367-74.
13. Ozdemir S, Tandogan B, Ulusu NN, Turan B. Angiotensin II receptor blockage prevents diabetic induced oxidative damage in rat heart. Folia Biol 2009; 55: 11-6.
14. Miura S, Kiya Y, Kanazawa T, Imaizumi S, Fujino M, Matsuo Y, et al. Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol 2008; 22: 139-46.
15. Bhuiyan MA, Ishiguro M, Hossain M, Nakamura T, Ozaki M, Miura S, et al. Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling. Life Sci 2009; 85: 136-40.
16. Miura S, Saku K, Karnik SS. Molecular analysis of the structure and function of the Angiotensin II type 1 receptor. Hypertens Res 2003; 26: 937-43.